A Prospective, Randomized, Open, Multicenter Study to Evaluate the Efficacy and Tolerability of Induction Therapy With a Single High-Dose Anti-T-Lymphocyte Globulin (ATG) in Renal Transplant Patients With a Kidney From a Non-Heart-Beating Donor and Tacrolimus, Mycophenolate Mofetil, and Steroids as Basic Immunosuppression.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Incidence of initial delayed graft function (defined as need for dialysis)
Within three months after transplantation
andries hoitsma, prof.dr.
UMC St Radboud Hospital, Nijmegen, the Netherlands
Netherlands: Medical Ethics Review Committee (METC)